Table 6.
Melatonin or 6-hydroxymelatonin ng/ml | Mitochondrial membrane potential Red/green fluorescence ratio | Oxygen consumption nMoles O2/min/mg protein | Total radical production ΔFluorescence x 103/min/106 cells | Mitochondrial superoxide production Fluorescence units ×103 |
---|---|---|---|---|
Solvent control | 23.9 [18.3–27.0] | 17.9 [14.2–27.2] | 56 [34–61] | 260 [250–270] |
Melatonin + LPS/PepG | P < 0.0001 | P < 0.0001 | P < 0.0001 | P = 0.0029 |
0 | 28.6 [21.1–33.3] # | 36.1 [23.0–56.2] # | 88 [51–127] # | 290 [270–310] # |
0.01 | 21.6 [15.9–24.3]* | 27.4 [18.6–38.6]* | 59 [39–97]* | 280 [270–300]* |
0.1 | 19.9 [15.8–24.3]* | 22.6 [16.3–32.4]* | 62 [38–80]* | 270 [250–300]* |
1 | 21.0 [14.5–25.8]* | 24.3 [18.2–41.5]* | 62 [37–97]* | 270 [260–300]* |
10 | 19.6 [15.6–28.3]* | 25.6 [20.5–36.8]* | 60 [37–91]* | 270 [250–300]* |
100 | 23.2 [15.4–26.7]* | 32.4 [25.7–43.4] | 59 [35–111]* | 270 [250–290]* |
1000 | 24.5 [15.2–28.6]* | 37.7 [28.1–48.4] | 66 [43–105]* | 270 [270–280]* |
Solvent control | 21.5 [16.1–23.3] | 19.0 [14.9–30.9] | 57 [41–70] | 250 [230–280] |
6-Hydroxymelatonin + LPS/PepG | P < 0.0001 | P = 0.0037 | P < 0.0001 | P = 0.0035 |
0 | 29.2 [21.8–32.8] # | 33.1 [21.1–53.4] # | 89 [60–122] # | 290 [260–300] # |
0.01 | 21.1 [16.1–23.3]* | 19.8 [13.8–26.7]* | 76 [45–117]* | 270 [250–300]* |
0.1 | 20.4 [17.2–23.9]* | 20.0 [12.9–25.2]* | 61 [46–108]* | 280 [270–300]* |
1 | 21.5 [19.1–26.7]* | 18.9 [15.1–25.2]* | 68 [40–93]* | 280 [260–300]* |
10 | 18.9 [15.8–24.4]* | 21.5 [14.8–25.9]* | 64 [50–110]* | 270 [250–300]* |
100 | 22.2 [18.9–25.0]* | 21.3 [15.3–26.7]* | 70 [54–109]* | 270 [260–300]* |
1000 | 24.6 [16.6–27.8]* | 19.4 [16.4–22.6]* | 61 [47–72]* | 270 [260–290]* |
6-OH Melatonin = 6-hydroxymelatonin. Median [interquartile range], n = 20. P-value shown is Friedman's test across LPS/PepG groups.
Significantly different from solvent control (Wilcoxon signed ranks) and *significantly different from LPS/PepG alone (Dunn's test) P < 0.05.